<DOC>
	<DOCNO>NCT00977444</DOCNO>
	<brief_summary>Abstract Kondrium , pharmaceutical composition treatment osteoarthritis ( OA ) . This study design evaluate efficacy safety kondrium treatment OA knee . A 3 month , randomize , double-blind , active-controlled , parallel-group study carry . 117 patient OA knee randomize receive 1 intra-articular monthly injection 5 mL one following : 75 mg/mL Kondrium , 82.5 mg/mL Kondriumf 8 mg/mL methylprednisolone month 3 month . The primary efficacy variable change baseline final assessment Western Ontario McMaster University OA index ( WOMAC subscale score pain ) , LequesneÂ´s functional index .</brief_summary>
	<brief_title>Evaluation New Formulation Useful Osteoarthrosis Treatment</brief_title>
	<detailed_description>The WOMAC osteoarthritis index validate , multidimensional , disease specific , health status measure . It probe clinically important patient relevant symptom area pain , stiffness physical function patient hip and/or knee osteoarthritis . It consist 24 question three separated subscales ( 5 question pain subscale , 17 question physical function subscales 2 question stiffness subscale ) , score analog scale 0 10 point ( 0 represent pain , 10 represent extreme pain ) . Each subscale score weigh 10 point , thus 30 maximum punctuation WOMAC total score . The Lequesne index 10-question interview-style survey give patient osteoarthritis knee . It 5 question pertain pain discomfort , 1 question deal maximum distance walk , 4 question daily activity . The total questionnaire score 0 24 scale , low score mean less functional impairment .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>age &gt; 40 year symptomatic evidence OA knee least 1 year radiographic evidence Kellgren Lawrence grade II IV OA knee intraarticular injection corticosteroid within last 3 month history adverse reaction study drug current pregnancy status uncontrolled hypertension active infection undergone surgery/arthroscopy within three month diagnosis radiographic OA Kellgren Lawrence grade I</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>knee</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>